3 results
8-K
EX-99.1
MRK
Merck & Co Inc
11 May 10
Regulation FD Disclosure
12:00am
focus on lifecycle management to satisfy local customer needs Expand our low-cost manufacturing network Increase investment in clinical trials across
8-K
EX-99.2
MRK
Merck & Co Inc
21 Nov 03
Financial statements and exhibits
12:00am
Requires investments in sales force, Phase IV, and lifecycle management Growth Drivers: ZETIA and REMICADE Loss of Losec Alliance Revenue, Continued
- Prev
- 1
- Next